RxDoctor Payments Data
★ My doctorsLook up a doctor →

Pramod Gaudel, MD

Hematology & Oncology · Athens, GANPI 1235506825

Payments from drug & device makers

$9,472in general payments, 2019–2025

Across 412 payments — averaging $22.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$841
  • Pfizer$679
  • Merck$662
  • AbbVie$506
  • Daiichi Sankyo Inc.$482
  • Genentech USA, Inc.$432
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$9,41699%
  • Education$551%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)35$841
Pfizer35$679
Merck25$662
AbbVie22$506
Daiichi Sankyo Inc.17$482
Genentech USA, Inc.21$432
Bristol Myers Squibb18$430
Takeda Pharmaceuticals U.S.A., Inc.14$374
Sanofi12$321
Jazz Pharmaceuticals Inc.10$312
GSK12$299
Novartis12$257
Johnson & Johnson(2 entities)11$232
Astellas Pharma US Inc8$192
Regeneron Healthcare Solutions, Inc.7$176
Eisai Inc.8$166
Sobi, Inc8$159
Incyte Corporation8$153
Gilead(2 entities)6$142
Stemline Therapeutics Inc.5$140
Adaptive Biotechnologies Corporation6$130
Pharmaessentia USA Corporation5$120
ADC Therapeutics America, Inc.5$109
Puma Biotechnology, Inc.5$108
Lilly USA, LLC5$108
Array Biopharma Inc8$103
Exelixis Inc.4$102
Bayer4$101
Rigel Pharmaceuticals, Inc.5$99
Beone Medicines USA, Inc.4$96
Dendreon Pharmaceuticals LLC3$94
Karyopharm Therapeutics Inc.4$88
EMD Serono, Inc.3$73
Azurity Pharmaceuticals, Inc.3$66
Beigene USA, Inc.3$66
Coherus Oncology, Inc.3$64
Geron Corporation3$62
Amgen3$54
Servier Pharmaceuticals LLC3$53
AVEO Pharmaceuticals, Inc.2$46
Deciphera Pharmaceuticals Inc.2$46
Recordati_rare_diseases_inc.2$42
Blueprint Medicines Corporation2$40
Genmab U.S., Inc.2$39
Iovance Biotherapeutics, Inc.2$39
Legend Biotech USA Inc.2$37
Seagen Inc.2$36
Fennec Pharmaceuticals, Inc.2$32
Tersera Therapeutics LLC1$32
Sun Pharmaceutical Industries Inc.1$32
Apellis Pharmaceuticals, Inc.1$31
Boehringer Ingelheim1$30
Taiho Oncology, Inc.1$28
Sumitomo Pharma America, Inc.1$26
Acrotech Biopharma Inc.1$26
Mirati Therapeutics, Inc.1$25
Spectrum Pharmaceuticals Inc.1$24
Ipsen Biopharmaceuticals, Inc1$24
Tempus AI, Inc1$21
Immunocore Limited1$21

How this compares

$9,472 in reported general payments places this provider in the 50th percentile of 370 hematology & oncology providers in Georgia.

See all hematology & oncology providers in Georgia →

Medicare billing

Part B allowed, 2024
$100,782
Medicare patients
50
Services billed
4,258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Athens

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →